Skip to main content
Top
Published in: Molecular Cancer 1/2014

Open Access 01-12-2014 | Short communication

Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases

Authors: Chiara Arrigoni, Paola De Luca, Mara Gilardi, Sara Previdi, Massimo Broggini, Matteo Moretti

Published in: Molecular Cancer | Issue 1/2014

Login to get access

Abstract

Background

Bone metastases arise in nearly 70% of patients with advanced breast cancer, but the complex metastatic process has not been completely clarified yet. RANKL/RANK/OPG pathway modifications and the crosstalk between metastatic cells and bone have been indicated as potential drivers of the process. Interactions between tumor and bone cells have been studied in vivo and in vitro, but specific effects of the direct contact between human metastatic cells and human bone cells on RANKL/RANK/OPG pathway have not been investigated.

Findings

We directly co-cultured bone metastatic human breast cancer cells (BOKL) with osteo-differentiated human mesenchymal cells (BMSCs) from 3 different donors. BMSCs and BOKL were then enzymatically separated and FACS sorted. We found a significant increase in the RANKL/OPG ratio as compared to control, which was not observed in BOKL cultured in medium conditioned by BMSCs, neither in BOKL directly cultured with fibroblasts or medium conditioned by fibroblasts. Direct co-culture with osteo-differentiated BMSCs caused BOKL aggregation while proliferation was not affected by co-culture. To more specifically associate RANKL expression to osteogenic differentiation degree of BMSCs, we determined their osteogenic markers expression and matrix calcification relative to osteoblasts and fibroblasts.

Conclusions

In conclusion, our co-culture model allowed to demonstrate for the first time that direct contact but not paracrine interactions between human metastatic breast cancer cells and bone cells has a significant effect on RANKL/OPG expression in bone metastatic cells. Furthermore, only direct contact with the bone microenvironment induced BOKL clustering without however significantly influencing their proliferation and migration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dougall WC: Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer Res. 2012, 18: 326-335. 10.1158/1078-0432.CCR-10-2507CrossRefPubMed Dougall WC: Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer Res. 2012, 18: 326-335. 10.1158/1078-0432.CCR-10-2507CrossRefPubMed
2.
go back to reference Hofbauer LC, Schoppet M: Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004, 292: 490-495. 10.1001/jama.292.4.490CrossRefPubMed Hofbauer LC, Schoppet M: Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004, 292: 490-495. 10.1001/jama.292.4.490CrossRefPubMed
3.
go back to reference Canon JR, Roudier M, Bryant R, Morony S, Stolina M, Kostenuik PJ, Dougall WC: Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clin Exp Metastasis. 2008, 25: 119-129. 10.1007/s10585-007-9127-1CrossRefPubMed Canon JR, Roudier M, Bryant R, Morony S, Stolina M, Kostenuik PJ, Dougall WC: Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis. Clin Exp Metastasis. 2008, 25: 119-129. 10.1007/s10585-007-9127-1CrossRefPubMed
4.
go back to reference Chaffer CL, Weinberg RA: A perspective on cancer cell metastasis. Science. 2011, 331: 1559-1564. 10.1126/science.1203543CrossRefPubMed Chaffer CL, Weinberg RA: A perspective on cancer cell metastasis. Science. 2011, 331: 1559-1564. 10.1126/science.1203543CrossRefPubMed
5.
go back to reference Krishnan V, Shuman LA, Sosnoski DM, Dhurjati R, Vogler EA, Mastro AM: Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures. J Cell Physiol. 2011, 226: 2150-2158. 10.1002/jcp.22550CrossRefPubMed Krishnan V, Shuman LA, Sosnoski DM, Dhurjati R, Vogler EA, Mastro AM: Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures. J Cell Physiol. 2011, 226: 2150-2158. 10.1002/jcp.22550CrossRefPubMed
6.
go back to reference Giunciuglio D, Cai T, Filanti C, Manduca P, Albini A: Effect of osteoblast supernatants on cancer cell migration and invasion. Cancer Lett. 1995, 97: 69-74. 10.1016/0304-3835(95)03955-VCrossRefPubMed Giunciuglio D, Cai T, Filanti C, Manduca P, Albini A: Effect of osteoblast supernatants on cancer cell migration and invasion. Cancer Lett. 1995, 97: 69-74. 10.1016/0304-3835(95)03955-VCrossRefPubMed
7.
go back to reference Pohorelic B, Singh R, Parkin S, Koro K, Yang AD, Egan C, Magliocco A: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment. Breast Cancer Res Treat. 2012, 133: 201-214. 10.1007/s10549-011-1753-2CrossRefPubMed Pohorelic B, Singh R, Parkin S, Koro K, Yang AD, Egan C, Magliocco A: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment. Breast Cancer Res Treat. 2012, 133: 201-214. 10.1007/s10549-011-1753-2CrossRefPubMed
8.
go back to reference Hsu YL, Hou MF, Kuo PL, Huang YF, Tsai EM: Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene. 2013, 32: 4436-4447. 10.1038/onc.2012.444CrossRefPubMed Hsu YL, Hou MF, Kuo PL, Huang YF, Tsai EM: Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene. 2013, 32: 4436-4447. 10.1038/onc.2012.444CrossRefPubMed
9.
go back to reference Rajski M, Vogel B, Baty F, Rochlitz C, Buess M: Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer. PLoS One. 2012, 7: e29743- 10.1371/journal.pone.0029743PubMedCentralCrossRefPubMed Rajski M, Vogel B, Baty F, Rochlitz C, Buess M: Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer. PLoS One. 2012, 7: e29743- 10.1371/journal.pone.0029743PubMedCentralCrossRefPubMed
10.
go back to reference Molloy AP, Martin FT, Dwyer RM, Griffin TP, Murphy M, Barry FP, O’Brien T, Kerin MJ: Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer. 2009, 124: 326-332. 10.1002/ijc.23939CrossRefPubMed Molloy AP, Martin FT, Dwyer RM, Griffin TP, Murphy M, Barry FP, O’Brien T, Kerin MJ: Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer. 2009, 124: 326-332. 10.1002/ijc.23939CrossRefPubMed
11.
go back to reference Czekanska EM, Stoddart MJ, Richards RG, Hayes JS: In search of an osteoblast cell model for in vitro research. Eur Cell Mater. 2012, 24: 1-17.PubMed Czekanska EM, Stoddart MJ, Richards RG, Hayes JS: In search of an osteoblast cell model for in vitro research. Eur Cell Mater. 2012, 24: 1-17.PubMed
12.
go back to reference Borowsky AD: Choosing a mouse model: experimental biology in context–the utility and limitations of mouse models of breast cancer. Cold Spring Harb Perspect Biol. 2011, 3: a009670-PubMedCentralCrossRefPubMed Borowsky AD: Choosing a mouse model: experimental biology in context–the utility and limitations of mouse models of breast cancer. Cold Spring Harb Perspect Biol. 2011, 3: a009670-PubMedCentralCrossRefPubMed
13.
go back to reference Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003, 3: 537-549. 10.1016/S1535-6108(03)00132-6CrossRefPubMed Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003, 3: 537-549. 10.1016/S1535-6108(03)00132-6CrossRefPubMed
14.
go back to reference Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R: A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res. 2001, 16: 1486-1495. 10.1359/jbmr.2001.16.8.1486CrossRefPubMed Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R: A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res. 2001, 16: 1486-1495. 10.1359/jbmr.2001.16.8.1486CrossRefPubMed
15.
go back to reference Lopa S, Mercuri D, Colombini A, De Conti G, Segatti F, Zagra L, Moretti M: Orthopedic bioactive implants: hydrogel enrichment of macroporous titanium for the delivery of mesenchymal stem cells and strontium. J Biomed Mater Res A. 2013, 12: 3396-3403.CrossRef Lopa S, Mercuri D, Colombini A, De Conti G, Segatti F, Zagra L, Moretti M: Orthopedic bioactive implants: hydrogel enrichment of macroporous titanium for the delivery of mesenchymal stem cells and strontium. J Biomed Mater Res A. 2013, 12: 3396-3403.CrossRef
16.
go back to reference Tamura D, Hiraga T, Myoui A, Yoshikawa H, Yoneda T: Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol. 2008, 33: 17-24.PubMed Tamura D, Hiraga T, Myoui A, Yoshikawa H, Yoneda T: Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol. 2008, 33: 17-24.PubMed
17.
go back to reference Foroni C, Broggini M, Generali D, Damia G: Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev. 2012, 38: 689-697. 10.1016/j.ctrv.2011.11.001CrossRefPubMed Foroni C, Broggini M, Generali D, Damia G: Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev. 2012, 38: 689-697. 10.1016/j.ctrv.2011.11.001CrossRefPubMed
18.
go back to reference Leong MC, Vedula SR, Lim CT, Ladoux B: Geometrical constraints and physical crowding direct collective migration of fibroblasts. Commun Integr Biol. 2013, 6: e23197- 10.4161/cib.23197PubMedCentralCrossRefPubMed Leong MC, Vedula SR, Lim CT, Ladoux B: Geometrical constraints and physical crowding direct collective migration of fibroblasts. Commun Integr Biol. 2013, 6: e23197- 10.4161/cib.23197PubMedCentralCrossRefPubMed
19.
go back to reference Studebaker AW, Storci G, Werbeck JL, Sansone P, Sasser AK, Tavolari S, Huang T, Chan MW, Marini FC, Rosol TJ, Bonafè M, Hall BM: Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 2008, 68: 9087-9095. 10.1158/0008-5472.CAN-08-0400CrossRefPubMed Studebaker AW, Storci G, Werbeck JL, Sansone P, Sasser AK, Tavolari S, Huang T, Chan MW, Marini FC, Rosol TJ, Bonafè M, Hall BM: Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 2008, 68: 9087-9095. 10.1158/0008-5472.CAN-08-0400CrossRefPubMed
20.
go back to reference Cserni G, Bianchi S, Vezzosi V, van Diest P, van Deurzen C, Sejben I, Regitnig P, Asslaber M, Foschini MP, Sapino A, Castellano I, Callagy G, Arkoumani E, Kulka J, Wells CA: Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer. 2008, 44: 2185-2191. 10.1016/j.ejca.2008.06.033CrossRefPubMed Cserni G, Bianchi S, Vezzosi V, van Diest P, van Deurzen C, Sejben I, Regitnig P, Asslaber M, Foschini MP, Sapino A, Castellano I, Callagy G, Arkoumani E, Kulka J, Wells CA: Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer. 2008, 44: 2185-2191. 10.1016/j.ejca.2008.06.033CrossRefPubMed
21.
go back to reference Maheshwari G, Lauffenburger DA: Deconstructing (and reconstructing) cell migration. Microsc Res Tech. 1998, 43: 358-368. 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-DCrossRefPubMed Maheshwari G, Lauffenburger DA: Deconstructing (and reconstructing) cell migration. Microsc Res Tech. 1998, 43: 358-368. 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-DCrossRefPubMed
22.
go back to reference Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM: Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cell Mater. 2012, 23: 13-27.PubMed Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM: Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cell Mater. 2012, 23: 13-27.PubMed
23.
go back to reference Long MW: Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis. 2001, 27: 677-690. 10.1006/bcmd.2001.0431CrossRefPubMed Long MW: Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis. 2001, 27: 677-690. 10.1006/bcmd.2001.0431CrossRefPubMed
24.
go back to reference Brown JM, Corey E, Lee ZD, True LD, Yun TJ, Tondravi M, Vessella RL: Osteoprotegerin and rank ligand expression in prostate cancer. Urology. 2001, 57: 611-616. 10.1016/S0090-4295(00)01122-5CrossRefPubMed Brown JM, Corey E, Lee ZD, True LD, Yun TJ, Tondravi M, Vessella RL: Osteoprotegerin and rank ligand expression in prostate cancer. Urology. 2001, 57: 611-616. 10.1016/S0090-4295(00)01122-5CrossRefPubMed
25.
go back to reference Peng X, Guo W, Ren T, Lou Z, Lu X, Zhang S, Lu Q, Sun Y: Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. PLoS One. 2013, 8: e58361- 10.1371/journal.pone.0058361PubMedCentralCrossRefPubMed Peng X, Guo W, Ren T, Lou Z, Lu X, Zhang S, Lu Q, Sun Y: Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. PLoS One. 2013, 8: e58361- 10.1371/journal.pone.0058361PubMedCentralCrossRefPubMed
Metadata
Title
Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases
Authors
Chiara Arrigoni
Paola De Luca
Mara Gilardi
Sara Previdi
Massimo Broggini
Matteo Moretti
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2014
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-13-238

Other articles of this Issue 1/2014

Molecular Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine